High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,036 followers.

RT @Osteoporosis_NL: !! High bone turnover elevates the risk of #denosumab-induced hypocalcemia | TCRM @DovePress https://t.co/D6Cc01sown

RT @Osteoporose_NL: !! High bone turnover elevates the risk of #denosumab-induced hypocalcemia | TCRM @DovePress https://t.co/D6Cc01sown

RT @Osteoporose_NL: !! High bone turnover elevates the risk of #denosumab-induced hypocalcemia | TCRM @DovePress https://t.co/D6Cc01sown

!! High bone turnover elevates the risk of #denosumab-induced hypocalcemia | TCRM @DovePress https://t.co/D6Cc01sown